Dipyridamole enhances the anti-cancer ability of aspirin against colorectal cancer by inducing apoptosis in an unfolded protein response-dependent manner

F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018)

Article  PubMed  Google Scholar 

J.H. Kim, Chemotherapy for colorectal cancer in the elderly. World J. Gastroenterol. 21, 5158–5166 (2015)

Article  CAS  PubMed  PubMed Central  Google Scholar 

P. Balakumar, Y.H. Nyo, R. Renushia, D. Raaginey, A.N. Oh, R. Varatharajan, S.A. Dhanaraj, Classical and pleiotropic actions of dipyridamole: Not enough light to illuminate the dark tunnel? Pharmacol. Res. 87, 144–50 (2014)

M. Keller, K. Rohlf, A. Glotzbach, G. Leonhardt, S. Luke, K. Derksen, O. Demirci, D. Gocener, M. AlWahsh, J. Lambert, C. Lindskog, M. Schmidt, W. Brenner, M. Baumann, E. Zent, M.L. Zischinsky, B. Hellwig, K. Madjar, J. Rahnenfuhrer, N. Overbeck, J. Reinders, C. Cadenas, J.G. Hengstler, K. Edlund, R. Marchan, Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2 + breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. J. Exp. Clin. Cancer Res. 42, 25 (2023)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Gao, C. Zhou, Y. Zhong, L. Shi, X. Luo, H. Su, M. Li, Y. Xu, N. Zhang, H. Zhou, Dipyridamole interacts with the N-terminal domain of HSP90 and antagonizes the function of the chaperone in multiple cancer cell lines. Biochem. Pharmacol. 207, 115376 (2023)

Article  CAS  PubMed  Google Scholar 

S.M. Ge, D.L. Zhan, S.H. Zhang, L.Q. Song, W.W. Han, Reverse screening approach to identify potential anti-cancer targets of dipyridamole. Am. J. Transl Res. 8, 5187–5198 (2016)

CAS  PubMed  PubMed Central  Google Scholar 

M.P. Thome, C. Borde, A.K. Larsen, J.A.P. Henriques, G. Lenz, A.E. Escargueil, V. Marechal, Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation. Antiviral Res. 172, 104615 (2019)

Article  CAS  PubMed  Google Scholar 

D. Spano, J.C. Marshall, N. Marino, D. De Martino, A. Romano, M.N. Scoppettuolo, A.M. Bello, V. Di Dato, L. Navas, G. De Vita, C. Medaglia, P.S. Steeg, M. Zollo, Dipyridamole prevents triple-negative breast-cancer progression. Clin. Exp. Metastasis 30, 47–68 (2013)

Article  CAS  PubMed  Google Scholar 

M.P. Thome, L.C. Pereira, G.R. Onzi, F. Rohden, M. Ilha, F.T. Guma, M.R. Wink, G. Lenz, Dipyridamole impairs autophagic flux and exerts antiproliferative activity on prostate cancer cells. Exp. Cell. Res. 382, 111456 (2019)

Article  CAS  PubMed  Google Scholar 

S. Zhou, H. Xu, Q. Tang, H. Xia, F. Bi, Dipyridamole enhances the cytotoxicities of trametinib against Colon cancer cells through combined targeting of HMGCS1 and MEK Pathway. Mol. Cancer Ther. 19, 135–146 (2020)

Article  CAS  PubMed  Google Scholar 

S. Choudhary, S. Sood, H.C. Wang, Dipyridamole intervention of breast cell carcinogenesis. Mol. Carcinog. 53, 243–252 (2014)

Article  CAS  PubMed  Google Scholar 

G.N. Tzanakakis, K.C. Agarwal, M.P. Vezeridis, Prevention of human pancreatic cancer cell-induced hepatic metastasis in nude mice by dipyridamole and its analog RA-233. Cancer 71, 2466–2471 (1993)

Article  CAS  PubMed  Google Scholar 

R.R. Mishra, N. Belder, S.A. Ansari, M. Kayhan, H. Bal, U. Raza, P.G. Ersan, U.M. Tokat, E. Eyupoglu, O. Saatci, P. Jandaghi, S. Wiemann, A. Uner, C. Cekic, Y. Riazalhosseini, O. Sahin, Reactivation of cAMP pathway by PDE4D Inhibition Represents a Novel Druggable Axis for overcoming tamoxifen resistance in ER-positive breast Cancer. Clin. Cancer Res. 24, 1987–2001 (2018)

Article  CAS  PubMed  Google Scholar 

J. Longo, P.J. Mullen, R. Yu, J.E. van Leeuwen, M. Masoomian, D.T.S. Woon, Y. Wang, E.X. Chen, R.J. Hamilton, J.M. Sweet, T.H. van der Kwast, N.E. Fleshner, L.Z. Penn, An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer. Mol. Metab. 25, 119–130 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

A. Mehta, B.M. Patel, Therapeutic opportunities in colon cancer: focus on phosphodiesterase inhibitors. Life Sci. 230, 150–161 (2019)

Article  CAS  PubMed  Google Scholar 

W. Huang, J. Sundquist, K. Sundquist, J. Ji, Phosphodiesterase-5 inhibitors use and risk for mortality and metastases among male patients with colorectal cancer. Nat. Commun. 11, 3191 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

W. Huang, J. Sundquist, K. Sundquist, J. Ji, Use of Phosphodiesterase 5 Inhibitors Is Associated With Lower Risk of Colorectal Cancer in Men With Benign Colorectal Neoplasms. Gastroenterology 157, 672–681 e4 (2019)

K. Krishnan, Z.K. Law, J.S. Minhas, P.M. Bath, T.G. Robinson, N. Sprigg, A. Mavilakandy, T.J. England, D. Eveson, A. Mistri, J. Dawson, J.P. Appleton, Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician. Clin. Med. (Lond) 22, 449–454 (2022)

Article  PubMed  Google Scholar 

X. Hou, K. Cen, Y. Cui, Y. Zhang, X. Feng, Antiplatelet therapy for secondary prevention of lacunar stroke: a systematic review and network meta-analysis. Eur. J. Clin. Pharmacol. 79, 63–70 (2023)

Article  CAS  PubMed  Google Scholar 

J. Hybiak, I. Broniarek, G. Kiryczynski, L.D. Los, J. Rosik, F. Machaj, H. Slawinski, K. Jankowska, E. Urasinska, Aspirin and its pleiotropic application. Eur. J. Pharmacol. 866, 172762 (2020)

Article  CAS  PubMed  Google Scholar 

A. Greco, S. Finocchiaro, D.J. Angiolillo, D. Capodanno, Advances in the Available Pharmacotherapy for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation (Expert Opin Pharmacother, 2023)

H. Hua, H. Zhang, Q. Kong, J. Wang, Y. Jiang, Complex roles of the old drug aspirin in cancer chemoprevention and therapy. Med. Res. Rev. 39, 114–145 (2019)

Article  CAS  PubMed  Google Scholar 

A. Grancher, P. Michel, F. Di Fiore, D. Sefrioui, Colorectal cancer chemoprevention: is aspirin still in the game? Cancer Biol. Ther. 23, 446–461 (2022)

Article  CAS  PubMed  PubMed Central  Google Scholar 

J. Ji, J. Sundquist, K. Sundquist, Use of terbinafine and risk of death in patients with prostate cancer: a population-based cohort study. Int. J. Cancer 144, 1888–1895 (2019)

Article  CAS  PubMed  Google Scholar 

T.G. Simon, A.S. Duberg, S. Aleman, R.T. Chung, A.T. Chan, J.F. Ludvigsson, Association of aspirin with Hepatocellular Carcinoma and Liver-Related mortality. N Engl. J. Med. 382, 1018–1028 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40, 373–383 (1987)

Article  CAS  PubMed  Google Scholar 

X.L. Zhang, L.P. Hu, Q. Yang, W.T. Qin, X. Wang, C.J. Xu, G.A. Tian, X.M. Yang, L.L. Yao, L. Zhu, H.Z. Nie, Q. Li, Q. Xu, Z.G. Zhang, Y.L. Zhang, J. Li, Y.H. Wang, S.H. Jiang, CTHRC1 promotes liver metastasis by reshaping infiltrated macrophages through physical interactions with TGF-beta receptors in colorectal cancer. Oncogene 40, 3959–3973 (2021)

Article  CAS  PubMed  Google Scholar 

T. Shimura, S. Toden, N.L. Komarova, C. Boland, D. Wodarz, A. Goel, A comprehensive in vivo and mathematic modeling-based kinetic characterization for aspirin-induced chemoprevention in colorectal cancer. Carcinogenesis 41, 751–760 (2020)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Zhao, O.O. Coker, J. Wu, Y. Zhou, L. Zhao, G. Nakatsu, X. Bian, H. Wei, A.W.H. Chan, J.J.Y. Sung, F.K.L. Chan, E. El-Omar, J. Yu, Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce its Bioavailability and Chemopreventive Effects. Gastroenterology 159, 969–983 e4 (2020)

T.C. Chou, P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27–55 (1984)

Article  CAS  PubMed  Google Scholar 

W. Huang da, B.T. Sherman, R.A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1–13 (2009)

Article  PubMed  Google Scholar 

W. Huang da, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 (2009)

Article  PubMed  Google Scholar 

A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, J.P. Mesirov, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U S A 102, 15545–15550 (2005)

Article  CAS  PubMed  PubMed Central  Google Scholar 

V.K. Mootha, C.M. Lindgren, K.F. Eriksson, A. Subramanian, S. Sihag, J. Lehar, P. Puigserver, E. Carlsson, M. Ridderstrale, E. Laurila, N. Houstis, M.J. Daly, N. Patterson, J.P. Mesirov, T.R. Golub, P. Tamayo, B. Spiegelman, E.S. Lander, J.N. Hirschhorn, D. Altshuler, L.C. Groop, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003)

Article  CAS  PubMed  Google Scholar 

Y.X. Feng, E.S. Sokol, C.A. Del Vecchio, S. Sanduja, J.H. Claessen, T.A. Proia, D.X. Jin, F. Reinhardt, H.L. Ploegh, Q. Wang, P.B. Gupta, Epithelial-to-mesenchymal transition activates PERK-eIF2alpha and sensitizes cells to endoplasmic reticulum stress. Cancer Discov 4, 702–715 (2014)

Article  CAS  PubMed  Google Scholar 

S.T. Nawrocki, J.S. Carew, K. Dunner Jr., L.H. Boise, P.J. Chiao, P. Huang, J.L. Abbruzzese, D.J. McConkey, Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res. 65, 11510–11519 (2005)

Article  CAS  PubMed 

留言 (0)

沒有登入
gif